GF
ABBV icon

Gimbal Financial’s AbbVie ABBV Stock Holding History

Gimbal Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$721K Buy
3,112
+153
+5% +$31.2K 0.43% 23
2025
Q2 		$549K Buy
2,959
+4
+0.1% +$743 0.34% 22
2025
Q1 		$619K Buy
2,955
+18
+0.6% +$3.5K 0.56% 17
2024
Q4 		$522K Sell
2,937
-3
-0.1% -$552 0.43% 24
2024
Q3 		$558K Buy
2,940
+13
+0.4% +$2.43K 0.36% 23
2024
Q2 		$497K Buy
2,927
+3
+0.1% +$497 0.37% 23
2024
Q1 		$533K Buy
2,924
+2
+0.1% +$345 0.44% 22
2023
Q4 		$453K Buy
+2,922
New +$426K 0.45% 24

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gimbal Financial's ABBV Position: Q3 2025 in Review

Gimbal Financial increased its AbbVie (ABBV) stake by 5.2% in Q3 2025, buying an estimated $31.2K and bringing the position to 3,112 shares worth $721K. The position accounts for 0.43% of the portfolio, ranked #23.

Gimbal Financial first reported a position in ABBV in Q4 2023 and has held it in 8 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Gimbal Financial held 3,112 shares of AbbVie worth $721K as of Q3 2025.
  • Gimbal Financial bought 153 AbbVie shares in Q3 2025, an estimated $31.2K.
  • AbbVie made up 0.43% of Gimbal Financial's portfolio in Q3 2025, its #23 holding.
  • Gimbal Financial first reported a position in AbbVie in Q4 2023 and has held it in 8 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Gimbal Financial's 13F filing for Q3 2025, filed 4 Nov 2025.